Lv1
18 积分 2024-03-11 加入
Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies
1天前
已完结
Global patterns and trends in breast cancer incidence and mortality across 185 countries
3个月前
已完结
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial
3个月前
已完结
Utidelone plus pembrolizumab as the fourth-line combination treatment in non-small cell lung cancer with EGFR mutation: a case report
5个月前
已完结
Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor penetration
7个月前
已完结
Bystander effect of antibody–drug conjugates: fact or fiction?
7个月前
已完结
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer A Systematic Review and Meta-Analysis
9个月前
已关闭
Alpha-fetoprotein-producing gastric cancer with ruptured liver metastasis mimicking hepatocellular carcinoma
10个月前
已完结
Endometriosis Typology and Ovarian Cancer Risk
10个月前
已关闭
皖公网安备34019202002308
